I am so honored to receive the @fightblindness clinical research fellowship award working on an inherited retinal degenerative disease project. Thank you!
.@SparingVision has received authorization from the @US_FDA to launch a Phase 1/2 clinical trial known as PRODYGY for SPVN06, its gene-independent, cone-preserving therapy for people with retinitis pigmentosa (#RP). The U.S. trial will take place at @UPMC. https://t.co/x5rwGvezfe
During the 2022 fiscal year, the Foundation added 23 new research projects to its portfolio. One of the Career Development Awardees we'd like to highlight is Hamzah Aweidah (@Haweidah), MD, of the @UPMC. Learn more about this research project and others! https://t.co/1LB3gnEEfU
#NEIfunded research: patients receiving a retinal implant could simultaneously see with prosthetic central #vision and natural peripheral vision.
The future of restoring function?
@ByersEye @StanfordMed@Pitt_Ophtho@NatureComms: https://t.co/LLB7JBGBlr
I am so honored to receive the @fightblindness clinical research fellowship award working on an inherited retinal degenerative disease project. Thank you!
Congratulations to all of the #ARVO2021 honorees, participants, and organizers for a wonderful annual meeting!
We look forward to next year's meeting and celebrating 2022 Weisenfeld awardee Dr. Janey Wiggs!
Ready for a brain break? Visit the #ARVO2021 Media/Art Gallery in the Fun Zone to view beautiful images and inspiring videos from @ARVOinfo's talented membership (and potentially future members). https://t.co/sC5cJtKsFA
One hour left! So excited for the live discussion of my paper in the (Gen)omics and molecular mechanisms of ocular disease session #ARVO2021 meeting @ARVOinfo#Genetics#Colorblind
Say cheese #ARVO2021! If you need a brain break during the day, head over to the ARVO Fun Zone and let out your creative side in our virtual photo booth: https://t.co/TPnlQBfX7N